HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Single-dose mezlocillin prophylaxis in emergency cesarean section.

Abstract
A single 5-gm dose of mezlocillin or a placebo was administered intravenously 30 minutes before surgery to patients undergoing emergency cesarean section. The assignment of drug or placebo was randomized. Postoperative morbidity occurred in 62.5% of patients receiving placebo and in 18.4% of those receiving mezlocillin (P less than 0.001). The incidences of febrile morbidity, endometritis, and urinary tract infection were significantly lower in the group given mezlocillin. Other benefits of antibiotic prophylaxis included a shorter hospital stay and no serious infections in the group given mezlocillin.
AuthorsR Jaffe, M Altaras, I Cohen, N Ben-Aderet
JournalClinical therapeutics (Clin Ther) Vol. 7 Issue 4 Pg. 507-11 ( 1985) ISSN: 0149-2918 [Print] United States
PMID4016830 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Mezlocillin
Topics
  • Adult
  • Cesarean Section
  • Emergencies
  • Female
  • Humans
  • Mezlocillin (therapeutic use)
  • Pregnancy
  • Premedication
  • Random Allocation
  • Risk
  • Surgical Wound Infection (microbiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: